ImmuCell Corporation

Tri-Shield - First Defense - Brochure

First Defense Tri-Shield, approved by the USDA in November 2017, combines the E. coli and coronavirus antibodies contained in First Defense, with rotavirus antibody content to produce the only product on the market with trivalent protection against three of the leading pathogens that lead to calf scouring. Preventing scours in newborn calves reduces the need to use treatment antibiotics later in life. This new product will be available in a gel tube delivery format.

Most popular related searches

Contact supplier

Drop file here or browse